JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB314476

重组Anti-N6-methyladenosine (m6A)抗体[EPXVJ-1-2]

Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2]

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Monoclonal N6-methyladenosine (m6A) antibody. Suitable for FRET, Dot and reacts with Nucleic Acid samples. Cited in 2 publications.

查看别名

N6-methyladenosine, m6A

3 Images
Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)
  • Dot

Supplier Data

Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)

Dot blot analysis of N6-methyladenosine (m6A) using ab314476 at 1 : 5000 (0.106 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 20,000 dilution. Lane 1 : Hela (human cervical adenocarcinoma epithelial cell) total RNA Lane 2 : Hela (human cervical adenocarcinoma epithelial cell) mRNA Exposure time : 200s Blocking and diluting buffer and concentration : 5% NFDM/TBST

FRET - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)
  • FRET

Supplier Data

FRET - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)

A FRET-based assay was performed using 25 nm of each biotinylated oligo and ab314476 at a concentration range of 0.001-4.000 ug/ml. The Secondary antibody used was SA_D2 binding to antigen, GAR_tb binding to antibody at 1 : 100 dilution. Antigen : m6A RNA oligo, m6Am RNA oligo, Am RNA oligo, m6, 6A RNA oligo, m1A RNA oligo, m8A RNA oligo, m1G RNA oligo, m2G RNA oligo, A RNA oligo. Antigen concentration : 100 nmol/ml

Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)
  • Dot

Supplier Data

Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] (AB314476)

Dot blot analysis of N6-methyladenosine (m6A) using ab314476 at 1 : 5000 (0.106 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 20,000 dilution. Lane 1 : A-oligo Lane 2 : m6A-oligo Lane 3 : m6Am-oligo Lane 4 : Am-oligo Lane 5 : m6, 6A-oligo Lane 6 : m1A-oligo Lane 7 : m8A-oligo Lane 8 : m1G-oligo Lane 9 : m2G-oligo Exposure time : 5s Blocking and diluting buffer and concentration : 5% NFDM/TBST

不同偶联物与剂型 (1)

  • Carrier free

    Anti-N6-methyladenosine (m6A) antibody [EPXVJ-1-2] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPXVJ-1-2

亚型

IgG

不含载体蛋白

No

应用

FRET, Dot

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特异性

<p>This antibody targets both m6A and m6Am as seen in the FRET-based assay and Dot blot data, with a possible stronger preference for m6Am.</p>

style
left-column

搭配使用产品

Assay Kits

AB185912

m6A RNA Methylation Assay Kit (Colorimetric)

ELISA - m6A RNA Methylation Assay Kit (Colorimetric) (AB185912)

  • 0
  • 0
Primary Antibodies

AB151230

Anti-N6-methyladenosine (m6A) antibody

Nucleotide Array - Anti-N6-methyladenosine (m6A) antibody (AB151230)

  • 5
  • 3
Primary Antibodies

AB208577

Anti-N6-methyladenosine (m6A) antibody [17-3-4-1]

Immunoprecipitation - Anti-N6-methyladenosine (m6A) antibody [17-3-4-1] (AB208577)

  • 0
  • 0
Primary Antibodies

AB284130

Anti-N6-methyladenosine (m6A) antibody [EPR23561-164]

20ul selling size|RabMAb|Recombinant|Trial Size

Dot Blot - Anti-N6-methyladenosine (m6A) antibody [EPR23561-164] (AB284130)

  • 0
  • 0
Secondary Antibodies

AB7090

Goat Anti-Rabbit IgG H&L (HRP) preadsorbed

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (AB7090)

  • 5
  • 2
style
left-column

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FRET" : {"fullname" : "FRET", "shortname":"FRET"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Nucleic Acid": { "FRET-species-checked": "testedAndGuaranteed", "FRET-species-dilution-info": "0.001-4 µg/mL", "FRET-species-notes": "<p></p>", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/5000", "Dot-species-notes": "<p></p>" } } }
style
left-column

产品详情

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Conditional Ambient
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle
style
left-column

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

N6-methyladenosine (m6A) is a chemical modification present in RNA molecules specifically marking the adenosine base with a methyl group at the nitrogen-6 position. This modification weighing approximately 14 Da occurs in diverse eukaryotic species and influences RNA metabolism. m6A methylation can be detected using techniques like m6A dots blot or m6A ELISA. The modification is abundant in tissues like the brain and testis reflecting its critical role in varying cell types. Also m6A is known as a dynamic and reversible mark with its levels continuously adjusted by enzymes called writers (methyltransferases) erasers (demethylases) and readers (RNA-binding proteins).
Biological function summary

M6A methylation affects mRNA processing stability translation and decay. It integrates into large multi-protein complexes where it influences gene expression outcomes by affecting the RNA's interaction with the cellular machinery. This methylation modification acts as a regulatory signal that influences essential processes such as cell differentiation and circadian rhythms. Elucidating the biological functions of m6A involves studying how it affects RNA fate and its downstream gene regulatory networks.

Pathways

M6A modification is central to the mRNA metabolic pathway and the PI3K-Akt signaling pathway. It interacts with various proteins such as METTL3 an m6A methyltransferase which is vital for mediating m6A modification. It also interacts with YTH domain-containing proteins that recognize m6A marks influencing transcript dynamics and gene expression. The interplay of m6A with proteins in these pathways underlines its role in fine-tuning cellular processes and responses.

M6A modification has a significant impact on cancer and neurological disorders. In cancers alterations in m6A methylation patterns can promote oncogenic transformation and metastasis. m6A-related proteins such as FTO an m6A demethylase have shown connections to these pathways affecting cancer progression. In neurological disorders m6A impacts aspects of neural development and function and abnormalities in its regulation may contribute to diseases like Alzheimer's. Understanding the roles of m6A in diverse diseases can pave the way for novel therapeutic approaches.
style
left-column
style
left-column

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

靶点信息

See full target information N6-methyladenosine (m6A)
style
left-column

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

Cell & bioscience 15:61 PubMed40380235

2025

The HNRNPC/CELF2 signaling pathway drives glycolytic reprogramming and mitochondrial dysfunction in drug-resistant acute myeloid leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Ma,Haodong Li,Ziqi Zhao,Changchun Li,Man Wang,Lele Zhang,Yutong Zhao,Haipeng Su,Feng Wang,Jiai Hua

Clinics (Sao Paulo, Brazil) 80:100658 PubMed40245789

2025

Kynurenine promotes the immune escape of colorectal cancer cells via NAT10-mediated acC acetylation of PD-L1.

Applications

Unspecified application

Species

Unspecified reactive species

Zaibiao Wang,Manman Yin,Ruhang Zhou,Ming Li,Jie Peng,Zhengguang Wang
View all publications
style
left-column
style
left-column
style
right-column

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂，为您科研的每一步提供支持。若我们的产品未能达到预期性能，我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com